Retatrutide demonstrates mean weight reduction up to 24.2% at 48 weeks
Eli Lilly’s retatrutide - an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 and glucagon receptor -...
top of page
Browse by category
Search
SASI bypass safe but concerns over potential of malnutrition and excessive weight loss
Single anastomosis sleeve ileal (SASI) bypass appears to be an effective procedure for the treatment of morbid obesity and its related...
Potential role of bariatric in reducing future colorectal cancer
Bariatric surgery has the potential role in reducing future colorectal cancer (CRC) in patients with obesity at a population level,...
Australia Increasing health burden of type 2 diabetes
The total number of people with type 2 diabetes in Australia tripled - from 379,532 to 1,307,261— between 1990 and 2019 and while people...
Post-menopausal women with PCOS at increased cancer risk
Women with polycystic ovary syndrome (PCOS) are not at any greater risk of ovarian cancer than those without the common hormone condition...
Allurion and Medtronic to expand access to AI-powered weight loss programme
Allurion has entered a pilot collaboration agreement with Medtronic, to expand access to Allurion’s AI-powered weight loss programme...
1.3 billion people will have diabetes by 2050
More than half a billion people are living with diabetes worldwide, affecting men, women and children of all ages in every country, and...
BELIEVE study assessing bimagrumab for obesity completes enrolment
The BELIEVE global Phase 2b study - assessing bimagrumab as a single agent and in combination with semaglutide in patients with obesity -...
Journal Watch 21/06/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Novo Nordisk to protect US patients from unlawful sales of non-FDA approved ‘semaglutide medicines’
Novo Nordisk is taking multiple actions to protect US patients from the unlawful marketing and sales of non-FDA approved counterfeit and...
Browse by tag
bottom of page